SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001694665-23-000068
Filing Date
2023-06-08
Accepted
2023-06-08 16:10:21
Documents
14
Period of Report
2023-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evlo-20230608.htm   iXBRL 8-K 55139
2 EX-10.1 evlo-arplanexhibit101.htm EX-10.1 112964
6 evlo-20230608_g1.jpg GRAPHIC 7885
  Complete submission text file 0001694665-23-000068.txt   360976

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20230608.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20230608_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20230608_pre.xml EX-101.PRE 13049
8 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20230608_htm.xml XML 11276
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 231001989
SIC: 2834 Pharmaceutical Preparations